Table 1.
Demographic and transplant characteristics of study subjects
| IPS | Infection | p-value | |
|---|---|---|---|
| Recipient age (mean ± SD) | 47 ± 15 | 49 ± 16 | 0.727 |
| Gender (M/F) and % | 3/9 (25 / 75%) | 6/10 (37.5 / 62.5%) | 0.48 |
| Diagnosis | 0.61 | ||
| Acute Leukemia (AML/ALL) | 7 | 12 | |
| Lymphoma (HD/NHL) | 2 | 2 | |
| MDS/ Myeloproliferative disorder (MDS,myelofibrosis, PV) | 2 | 2 | |
| Chronic Leukemia (CLL) | 1 | 0 | |
| Type of transplant | 0.92 | ||
| Autologous | 1 | 1 | |
| Allogeneic | 10 | 13 | |
| Haploidentical NK cell infusion | 1 | 2 | |
| Donor Type | 0.66 | ||
| Unrelated donor | 8 | 13 | |
| Autologous | 1 | 1 | |
| Haploidentical | 3 | 2 | |
| Graft type | |||
| DUCBT | 5 | 13 | 0.067 |
| PBSCT | 5 | 1 | |
| Marrow | 1 | 0 | |
| Haploidentical NK cell infusion | 1 | 2 | |
| HLA match | 0.003 | ||
| Matched | 3 | 0 | |
| Mismatched | 5 | 16 | |
| Haploidentical | 3 | 0 | |
| Conditioning | 0.13 | ||
| Myeloablative | 3 | 9 | |
| Reduced intensity conditioning | 9 | 7 | |
| Recipient / donor CMV status | 0.079 | ||
| Positive / Negative | 3 | 11 | |
| Positive / Positive | 3 | 0 | |
| Negative / Negative | 4 | 4 | |
| Negative / Positive | 1 | 0 | |
| Positive (autologous transplant) | 1 | 1 | |
chi-square test for all except age.